Dyno’s Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board

Adeno-associated viruses (AAV) for gene therapy have received a ton of scrutiny throughout the field’s history after a smattering of safety scares and their limited therapeutic range. Hoping to crack the field wide open through a capsid design revolution, Eric Kelsic and his team at Dyno have drummed up immense...

Click to view original post